Xilio Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Xilio Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Xilio Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $4.73M, a 9.87% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.73M -$518K -9.87% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.87M -$498K -9.28% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5M -$479K -8.75% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.13M -$460K -8.24% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $5.25M -$442K -7.77% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.37M -$424K -7.32% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $5.48M -$408K -6.93% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $5.59M -$392K -6.56% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $5.69M -$376K -6.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $5.79M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $5.89M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5.98M -$332K -5.26% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $6.07M Sep 30, 2021 10-Q 2021-12-02
Q4 2020 $6.31M Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.